A new study from Karolinska University Hospital and Karolinska Institutet in collaboration with Uppsala University Hospital ...

Geneva, Switzerland: The first European Clinical Practice Guidelines (CPGs) for the diagnosis and management of Wilson's disease are published today by the European Association for the Study of the ...

Wilson’s disease is a rare genetic disorder in which copper accumulates in the body. It usually affects the liver and the brain, but can also involve the kidneys, the heart and the eyes. Symptoms are ...

Since the observation that injections of 2,3-dimer-captopropanol (BAL) benefit the neurologic symptoms 8 and, in 1 case, 9 may have benefited a patient in the "preneurologic" stage, it is of the ...

For decades, Wilson’s Disease has evaded comprehensive treatment. The wide-ranging physical and neurological symptoms of the condition have upended afflicted patients’ lives, with no potential cure in ...

Ultragenyx Pharmaceutical Inc. RARE announced that the FDA has cleared the Investigational New Drug (IND) application for UX701, being evaluated for the treatment of Wilson Disease. Wilson disease is ...

LONDON--(BUSINESS WIRE)--The global Wilson’s disease drugs market 2019-2023 is expected to post a CAGR of close to 6% during the forecast period, according to the latest market research report by ...

Wilson's Disease, also known as hepatolenticular degeneration, is a genetic disease involving the inability of the body to remove excess copper. Small amounts of copper are essential for normal living ...

A new study from Karolinska University Hospital and Karolinska Institutet in collaboration with Uppsala University Hospital and Uppsala University ...

Note: Diagnostic testing should meet conditions listed in either column labeled A, B, or C. Diagnostic tests: (A) molecular testing; or (B) slit lamp examination, serum ceruloplasmin (CP), and 24-hour ...